UPLIZNA

Viela Bio, Inc.

Application Filed: 2018-07-20
Trademark Application Details
Trademark Logo UPLIZNA

Mark For: UPLIZNA® trademark registration is intended to cover the category of pharmaceutical products for the treatment of rare autoimmune diseases and disorders. [all]

Status

2021-07-11 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number88045691
Registration Number6164646
Mark Literal ElementsUPLIZNA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2020-08-25
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameSusan Neuberger Weller
Attorney Docket Number054493405T01
Law Office AssignedM60
Employee NameFRENCH, CURTIS W

Timeline

2018-07-20Application Filed
2018-11-09Location: PUBLICATION AND ISSUE SECTION
2018-12-18Published
2018-12-18Published for Opposition
2018-12-18Status: Live/Pending
2019-01-04Transaction Date
2020-07-30Date of First Use
2020-07-30Date of Use In Commerce
2020-08-25Location: PUBLICATION AND ISSUE SECTION
2020-09-29Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2020-09-29Trademark Registered

Trademark Parties (Applicants & Owners)

Party: VIELA BIO, INC.
AddressOne MedImmune Way First Floor, Area Two Gaithersburg, MARYLAND UNITED STATES 20878
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingIMAGE/JPEG2018-07-20
TEAS RF New ApplicationAPPLICATION/XML,IMAGE/JPEG2018-07-20
Notation to FileXML2018-11-07
XSearch Search SummaryAPPLICATION/XML2018-11-07
TRAM Snapshot of App at Pub for OppostnMULTI2018-11-08
Notice of PublicationXML2018-11-28
Notification Of Notice of PublicationXML2018-11-28
OG Publication ConfirmationAPPLICATION/XML2018-12-18
Notice of AllowanceAPPLICATION/XML2019-02-12
Change of AddressAPPLICATION/XML2019-07-17
Extension of Time to File SOUXML2019-07-17
ITU Extension ApprovalAPPLICATION/XML2019-07-19
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2019-07-19
Extension of Time to File SOUAPPLICATION/XML2020-01-15
ITU Extension ApprovalAPPLICATION/XML2020-01-17
ITU Unit ActionMULTI2020-01-17
SpecimenJPEG2020-07-31
Statement of UseMULTI2020-07-31
ITU Unit ActionMULTI2020-08-13
Notice of Acceptance of Statement of UseAPPLICATION/XML2020-08-26
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2020-08-26
Registration CertificatePDF2020-09-29

Attorney of Record

SUSAN NEUBERGER WELLER
MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND
701 PENNSYLVANIA AVENUE, N.W.
SUITE 900
WASHINGTON, DC 20004

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical products for the treatment of rare autoimmune diseases and disorders. FIRST USE: 20200730. FIRST USE IN COMMERCE: 20200730

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical products for the treatment of rare autoimmune diseases and disorders
GS0051Pharmaceutical products for the treatment of rare autoimmune diseases and disorders

Trademark Filing History

DescriptionDateProceeding Number
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2021-03-31
REGISTERED-PRINCIPAL REGISTER2020-09-29
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2020-08-26
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2020-08-25
STATEMENT OF USE PROCESSING COMPLETE2020-08-1274055
CASE ASSIGNED TO INTENT TO USE PARALEGAL2020-08-1274055
USE AMENDMENT FILED2020-07-3174055
TEAS STATEMENT OF USE RECEIVED2020-07-31
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-01-17
TEAS EXTENSION RECEIVED2020-01-15
EXTENSION 2 GRANTED2020-01-1598765
EXTENSION 2 FILED2020-01-1598765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-07-19
TEAS EXTENSION RECEIVED2019-07-17
TEAS CHANGE OF CORRESPONDENCE RECEIVED2019-07-17
EXTENSION 1 GRANTED2019-07-1798765
EXTENSION 1 FILED2019-07-1798765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-02-12
PUBLISHED FOR OPPOSITION2018-12-18
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2018-12-18
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2018-11-28
APPROVED FOR PUB - PRINCIPAL REGISTER2018-11-07
ASSIGNED TO EXAMINER2018-11-0676419
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-07-25
NEW APPLICATION ENTERED IN TRAM2018-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed